Switch theme
Sign up to access all valuation multiples
Airway Medix SA focuses on research, development and commercialization of devices for single use in mechanically ventilated patients at Intensive Care Units as well as in patients with life-threatening and anaesthesiologic wards. The company's products include Closed Suction System, Oral Care System and Cuff Pressure Regulator.
2013
8
Last FY Revenue $3K
Last FY EBITDA -$3.0M
$15.0M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Airway Medix achieved revenue of $3K and an EBITDA of -$3.0M.
Airway Medix expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Airway Medix valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $3K | XXX | XXX | XXX |
| Gross Profit | XXX | -$2K | XXX | XXX | XXX |
| Gross Margin | XXX | -50% | XXX | XXX | XXX |
| EBITDA | XXX | -$3.0M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -91042% | XXX | XXX | XXX |
| EBIT | XXX | -$1.4M | XXX | XXX | XXX |
| EBIT Margin | XXX | -42150% | XXX | XXX | XXX |
| Net Profit | XXX | -$3.3M | XXX | XXX | XXX |
| Net Margin | XXX | -97792% | XXX | XXX | XXX |
| Net Debt | XXX | $5.5M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 3, 2025, Airway Medix's stock price is PLN 0 (or $0).
Airway Medix has current market cap of PLN 32.7M (or $9.1M), and EV of PLN 53.8M (or $15.0M).
See Airway Medix trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $15.0M | $9.1M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 3, 2025, Airway Medix has market cap of $9.1M and EV of $15.0M.
Airway Medix's trades at 4483.8x EV/Revenue multiple, and -4.9x EV/EBITDA.
Equity research analysts estimate Airway Medix's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Airway Medix's P/E ratio is not available.
See valuation multiples for Airway Medix and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $9.1M | XXX | $9.1M | XXX | XXX | XXX |
| EV (current) | $15.0M | XXX | $15.0M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 4483.8x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -4.9x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -10.6x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -2.8x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -7.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAirway Medix's revenue per employee in the last FY averaged $0K, while opex per employee averaged $0.2M for the same period.
Airway Medix's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Airway Medix's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Airway Medix and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -91042% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 42100% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
| Polymed | XXX | XXX | XXX | XXX | XXX | XXX |
| Farmaceutica Remedia | XXX | XXX | XXX | XXX | XXX | XXX |
| Etropal | XXX | XXX | XXX | XXX | XXX | XXX |
| Sopharma | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Airway Medix acquired XXX companies to date.
Last acquisition by Airway Medix was XXXXXXXX, XXXXX XXXXX XXXXXX . Airway Medix acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Airway Medix founded? | Airway Medix was founded in 2013. |
| Where is Airway Medix headquartered? | Airway Medix is headquartered in Poland. |
| How many employees does Airway Medix have? | As of today, Airway Medix has 8 employees. |
| Is Airway Medix publicy listed? | Yes, Airway Medix is a public company listed on WAR. |
| What is the stock symbol of Airway Medix? | Airway Medix trades under AWM ticker. |
| When did Airway Medix go public? | Airway Medix went public in 2014. |
| Who are competitors of Airway Medix? | Similar companies to Airway Medix include e.g. Ansell, Polymed, Farmaceutica Remedia, Etropal. |
| What is the current market cap of Airway Medix? | Airway Medix's current market cap is $9.1M |
| Is Airway Medix profitable? | Yes, Airway Medix is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
